Table 4. Results from Astym Delayed Entry Group.

Astym treatment was provided starting at 8 weeks to recalcitrant eccentric subjects who completed their eccentric exercise program but continued to have unresolved symptoms and then opted to receive Astym treatment.

Measure	0–4 weeks eccentric	4–8 weeks (no treatment)	8–12 weeks astym delayed entry
Primary outcome measure
DASH	Decrease 0.64%	Decrease 0.60%	Decrease 13.43%
	F = 0.07; p = 0.79	F = 0.17; p = 0.69	F = 35.81; p < 0.005
	Effect size 0.004	Effect size 0.01	Effect size 0.7
	Power 0.06	Power 0.07	Power 1.00
Secondary outcome measures
Pain with activity (VAS)	Decrease 3.1 mm	Decrease 3.1 mm	Decrease 26.1 mm
	F = 0.22; p = 0.64	F = 0.41; p = 0.53	F = 12.91; p = 0.002
	Effect size 0.01	Effect size 0.03	Effect size 0.45
	Power 0.07	Power 0.09	Power 0.92
Maximum grip strength	Decrease 12.1 lbs	Increase 2.8 lbs	Increase 6.3 lbs
	F = 10.46; p = 0.006	F = 0.31; p = 0.59	F = 1.10; p = 0.31
	Effect size 0.42	Effect size 0.02	Effect size 0.07
	Power 0.85	Power 0.08	Power 0.17
Function (VAS)	Increase 13 mm	Decrease 1.2 mm	Increase 17 mm
	F = 3.59; p = 0.08	F = 0.05; p = 0.83	F = 11.3; p = 0.004
	Effect size 0.14	Effect size 0.003	Effect size 0.41
	Power 0.34	Power 0.06	Power 0.88

Notes.

Shaded areas are statistically significant improvements in the Astym Delayed Entry Group.